Swapnil Bhargava
Chief Tech/Sci/R&D Officer at CG ONCOLOGY, INC.
Network origin in Swapnil Bhargava first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Swapnil Bhargava via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NCI INC | Information Technology Services | Corporate Officer/Principal | |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| New Jersey City University | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member | |
| Claremont Graduate University | College/University | Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Fudan University | College/University | Undergraduate Degree | |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| COWEN INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Medical Specialties | Director/Board Member | |
| UW Medicine | College/University | Graduate Degree | |
| Rush Medical College | College/University | Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member | |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Shenzhen GeneMDx Biotech Co., Ltd.
 Shenzhen GeneMDx Biotech Co., Ltd. BiotechnologyHealth Technology Shenzhen GeneMDx Biotech Co., Ltd. manufactures biologique products. It engages in domestic sales of medical equipments and diagnosis reagents. The company was founded on June 23, 2011 and is headquartered in Shenzhen, China. | Biotechnology | Director/Board Member | |
| FULGENT GENETICS, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Moffitt Technologies Corp. | Director/Board Member | ||
| UW Graduate School | College/University | Doctorate Degree | |
ORI Capital Investment Advisory Hong Kong Ltd.
 ORI Capital Investment Advisory Hong Kong Ltd. Investment ManagersFinance ORI Capital Investment Advisory Hong Kong Ltd (ORI Capital) is a venture capital firm in Hong Kong. The firm was founded by Simone Song in 2015. The firm is headquartered in Hong Kong. | Investment Managers | Consultant / Advisor | |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member | |
| Decheng Capital LLC (United States) | Director/Board Member | ||
Themes Investment Partners Fund
 Themes Investment Partners Fund Investment ManagersFinance Themes Investment Partners Fund invests in companies located in China. The fund focuses on wide variety of sectors. It provides financing for buyout & special situation transactions and also makes co-investments. | Investment Managers | Corporate Officer/Principal | |
Take2 Consulting LLC
 Take2 Consulting LLC Personnel ServicesCommercial Services Take2 Consulting LLC operates a platform for collaborative IT support resources. It offers cyber security, devops, mobility, big data, and engineering solutions. The company was founded by Serge Khoury in 2014 and is headquartered in Vienna, VA. | Personnel Services | Director/Board Member | |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Cellares Corp.
 Cellares Corp. Packaged SoftwareTechnology Services Cellares Corp. operates as a biotechnology company. It provides preclinical and clinical scientists as well as commercial cell therapy manufacturers. The company was founded by Omar Kurdi, Fabian Gerlinghaus and Alex Pesch in 2019 and is headquartered in South San Francisco, CA. | Packaged Software | Director/Board Member | |
Cirina, Inc.
 Cirina, Inc. Medical/Nursing ServicesHealth Services Part of Illumina, Inc., Cirina, Inc. is an American company that operates medical laboratories. The company is located in the US. | Medical/Nursing Services | Director/Board Member | |
Watchmaker Genomics, Inc.
 Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Biotechnology | Director/Board Member | |
| Hummingbird Bioscience | Director/Board Member | ||
| LEPU BIOPHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Translational Research In Oncology | Corporate Officer/Principal |
Statistics
International
| United States | 42 |
| China | 5 |
| Hong Kong | 3 |
| United Kingdom | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 14 |
| Finance | 6 |
| Technology Services | 5 |
| Health Services | 4 |
Operational
| Director/Board Member | 49 |
| Corporate Officer/Principal | 16 |
| Undergraduate Degree | 11 |
| Independent Dir/Board Member | 10 |
| Chief Tech/Sci/R&D Officer | 10 |
Most connected contacts
| Insiders | |
|---|---|
| Leonard Post | 25 |
| Victor Tong | 20 |
| James Mulé | 14 |
| Susan Graf | 9 |
| Ambaw Bellete | 9 |
| Vijay Kasturi | 6 |
| Hong Fang Song | 5 |
| Jue Pu | 5 |
| Brian Liu | 5 |
| Arthur Kuan | 4 |
| Bing Kung | 3 |
- Stock Market
- Insiders
- Swapnil Bhargava
- Company connections
